OOIR: Observatory of International Research

Papers

(The median citation count of Seminars in Nuclear Medicine is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Limitations and Pitfalls of FDG-PET/CT in Infection and Inflammation	57
Artificial Intelligence and Machine Learning in Nuclear Medicine: Future Perspectives	54
Imaging of COVID-19: CT, MRI, and PET	47
Application of Deep Learning in Breast Cancer Imaging	47
Brain [F-18]FDG PET for Clinical Dementia Workup: Differential Diagnosis of Alzheimer's Disease and Other Types of Dementing Disorders	43
Imaging of Head and Neck Cancer With CT, MRI, and US	41
Academic integrity and artificial intelligence: is ChatGPT hype, hero or heresy?	41
Imaging of Tumor Hypoxia for Radiotherapy: Current Status and Future Directions	40
Ischemic Heart Disease: An Update	40
PET and SPECT Tracers for Myocardial Perfusion Imaging	39
Intelligent Imaging in Nuclear Medicine: the Principles of Artificial Intelligence, Machine Learning and Deep Learning	37
Ethical and Legal Challenges of Artificial Intelligence in Nuclear Medicine	35
[18F]FDG-PET/CT Radiomics and Artificial Intelligence in Lung Cancer: Technical Aspects and Potential Clinical Applications	33
PET/MR in Head and Neck Cancer – An Update	31
Clinical Management of COVID-19 Patients – An Update	31
Radiomics in PET/CT: Current Status and Future AI-Based Evolutions	30
Advances in Brain Amyloid Imaging	30
Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors	28
Imaging of Tau Pathology in Neurodegenerative Diseases: An Update	28
Coronavirus Disease 2019 (COVID-19) in Molecular Imaging: A Systematic Review of Incidental Detection of SARS-CoV-2 Pneumonia on PET Studies	26
FDG PET/CT for Assessment of Immune Therapy: Opportunities and Understanding Pitfalls	25
FDG-PET/CT of COVID-19 and Other Lung Infections	25
Recent Developments in SPECT/CT	25
Artificial Intelligence for Optimization and Interpretation of PET/CT and PET/MR Images	23
PET Agents in Dementia: An Overview	22

Application and Translation of Artificial Intelligence to Cardiovascular Imaging in Nuclear Medicine and Noncontrast CT	22
FDG-PET/CT for Primary Staging and Detection of Recurrence of Breast Cancer	22
Imaging for Response Assessment in Cancer Clinical Trials	22
Variants and Pitfalls in PET/CT Imaging of Gastrointestinal Cancers	21
Lymphoscintigraphy for Sentinel Node Mapping in Head and Neck Cancer	21
Sentinel Lymph Node Methods in Breast Cancer	21
A role of FDG-PET/CT for response evaluation in metastatic breast cancer?	20
15O-Water PET MPI: Current Status and Future Perspectives	19
16α-18F-fluoro-17β-Fluoroestradiol (FES): Clinical Applications for Patients With Breast Cancer	19
Clinical Use of PET/MR in Oncology: An Update	18
Social Asymmetry, Artificial Intelligence and the Medical Imaging Landscape	17
How to Design AI-Driven Clinical Trials in Nuclear Medicine	17
PET/CT Variants and Pitfalls in Gynecological Cancers	17
The Future of Cardiac Molecular Imaging	17
PET/CT Variants and Pitfalls in Prostate Cancer: What You Might See on PET and Should Never Forget	17
The Role of 18-F FDG PET/CT in Imaging of Endocarditis and Cardiac Device Infections	16
FAPI-avid nonmalignant PET/CT findings: An expedited systematic review	16
PET-CT for Staging and Detection of Recurrence of Head and Neck Cancer	16
Artificial Intelligence for the Characterization of Pulmonary Nodules, Lung Tumors and Mediastinal Nodes on PET/CT	16
Imaging for Target Delineation in Head and Neck Cancer Radiotherapy	16
PET Perfusion and Flow Assessment: Tomorrows’ Technology Today	15
Hyperpolarized MRI – An Update and Future Perspectives	15
Radiation Dosimetry in 177Lu-PSMA-617 Therapy	15
PET/CT Variants and Pitfalls in Bone and Soft Tissue Sarcoma	14
Digital PET vs Analog PET: Clinical Implications?	14
PET Imaging in Neurodegeneration and Neuro-oncology: Variants and Pitfalls	14
PET/CT in Bladder Cancer: An Update	14
Total-body PET/CT – First Clinical Experiences and Future Perspectives	14
Measurement of Glomerular Filtration Rate	14
PET/CT in Non-Hodgkin Lymphoma: An Update	13
Radiation Safety and Accidental Radiation Exposures in Nuclear Medicine	13
Hybrid Imaging of Vascular Cognitive Impairment	13
Diagnosis and Image-guided Therapy of Cardiac Left Ventricular Assist Device Infections	12
Cardiac PET/MRI: Current Clinical Status and Future Perspectives	12
Artificial Intelligence for Response Evaluation With PET/CT	12
A Role for FDG PET Radiomics in Personalized Medicine?	12
Quantitative SPECT/CT for Dosimetry of Peptide Receptor Radionuclide Therapy	12
PET/CT Variants and Pitfalls in Breast Cancers	12
Radiation Dose Modulation of Computed Tomography Component in Positron Emission Tomography/Computed Tomography	11
Advances in PET/CT Technology: An Update	11
The Role of Positron Emission Tomography in Pancreatic Cancer and Gallbladder Cancer	11
Cardiac Imaging With 123I-meta-iodobenzylguanidine and Analogous PET Tracers: Current Status and Future Perspectives	11
Role of Non-FDG-PET/CT in Head and Neck Cancer	11
Variants and Pitfalls of PET/CT in Neuroendocrine Tumors	11
Mediastinal Masses: 18F-FDG-PET/CT Features Based on the International Thymic Malignancy Interest Group Classification	11
Advancement in Production of Radiotracers	11
PET/CT in Surgical Planning for Head and Neck Cancer	11
Pitfalls on PET/MRI	11
PET/MR Technology: Advancement and Challenges	11
A Clinical Role of PET in Atherosclerosis and Vulnerable Plaques?	11

Pediatric Nephro-Urology: Overview and Updates in Diuretic Renal Scans and Renal Cortical Scintigraphy	10
Advancement and Future Perspective of FAPI PET/CT In Gynecological Malignancies	10
FDG PET/CT for Evaluation of Immunotherapy Response in Lung Cancer Patients	10
A Role of PET/MR in Breast Cancer?	10
SPECT and PET Radiotracers in Renal Imaging	10
Current Status and Future Perspective on Molecular Imaging and Treatment of Neuroblastoma	10
Parametric Imaging With Dynamic PET for Oncological Applications: Protocols, Interpretation, Current Applications and Limitations for Clinical Use	10
Nuclear medicine imaging methods of radiation-induced cardiotoxicity	9
The Impact of Radiopharmaceutical Therapy on Renal Function	9
Current Status of Myocardial Perfusion Imaging With New SPECT/CT Cameras	9
PET Imaging of Tumor Perfusion: A Potential Cancer Biomarker?	9
18F-FDG PET/CT for Evaluation of Post-Transplant Lymphoproliferative Disorder (PTLD)	9
FDG-PET/CT Variants and Pitfalls in Haematological Malignancies	9
Molecular Imaging of Fever of Unknown Origin: An Update	9
Evidence Base for the Use of PRRT	9
Imaging and Quantification of Cardiac Sarcoidosis	9
Multimodality Imaging and Artificial Intelligence for Tumor Characterization: Current Status and Future Perspective	9
PET/CT Normal Variants and Pitfalls in Pediatric Disorders	9
Myocardial Viability Testing by Positron Emission Tomography: Basic Concepts, Mini-Review of the Literature and Experience From a Tertiary PET Center	8
FDG PET/CT Imaging of Sarcoidosis	8
Imaging of Invasive Fungal Infections- The Role of PET/CT	8
PET Assessment of Cardiac Allograft Vasculopathy	8
The Impact of PSMA PET/CT Imaging in Prostate Cancer Radiation Treatment	8
“PET/CT Variants and Pitfalls in Lung Cancer and Mesothelioma”	8
Nuclear Medicine Departments in the Era of COVID-19	8
Advances in Preclinical PET	8
The Value of the Standardized Uptake Value (SUV) and Metabolic Tumor Volume (MTV) in Lung Cancer	8
PET/CT in Hodgkin Lymphoma: An Update	7
Molecular Imaging of Tuberculosis	7
Iodine-131 and Iodine-131-Meta-iodobenzylguanidine Dosimetry in Cancer Therapy	7
Histopathologically Validated Diagnostic Accuracy of PSMA-PET/CT in the Primary and Secondary Staging of Prostate Cancer and the Impact of PSMA-PET/CT on Clinical Management: A Systematic Review and M	7
Hybrid PET/MRI in Infection and Inflammation: An Update About the Latest Available Literature Evidence	7
PET/CT Variants and Pitfalls in Head and Neck Cancers Including Thyroid Cancer	7
Modern PET-Guided Radiotherapy Planning and Treatment for Malignant Lymphoma	7
Update on Management of Medullary Thyroid Carcinoma: Focus on Nuclear Medicine	7
Update on Imaging of Inflammatory Arthritis and Related Disorders	7
Preclinical Development in Radiopharmaceutical Therapy for Prostate Cancer	7
Recent Advancements in CT and MR Imaging of Prostate Cancer	7
New PET Tracers: Current Knowledge and Perspectives in Lung Cancer	7
Molecular and Anatomical Imaging of Dementia With Lewy Bodies and Frontotemporal Lobar Degeneration	7
PET/CT Limitations and Pitfalls in Urogenital Cancers	7
Interim FDG-PET/CT for Response Assessment of Lymphoma	7
Multimodality Imaging in the Evaluation and Management of Cardiac Amyloidosis	7
The Peritoneum: What Nuclear Radiologists Need to Know	7
Molecular Imaging and Therapy of Colorectal and Anal Cancer	6
PSMA PET/CT for Primary Staging of Prostate Cancer - An Updated Overview	6
Pitfalls of Radionuclide Renal Imaging in Pediatrics	6
Vascular Graft Infection Imaging	6
Telehealth in Multidisciplinary Target Delineation for Radiotherapy During the COVID-19 Pandemic. A Review and a Case	6
Safe Pulmonary Scintigraphy in the Era of COVID-19	6
Pitfalls on PET/CT Due to Artifacts and Instrumentation	6
Remote Reading and Teaching of Nuclear Medicine in the Era of COVID-19	6
Added Value of Respiratory Gating in Positron Emission Tomography for the Clinical Management of Lung Cancer Patients	6
The Impact of COVID-19 on Nuclear Medicine in Europe	5
Future Imaging in Dementia	5
A role of FDG PET/CT for Response Assessment in Large Vessel Disease?	5
18F-FDG PET/CT for Response Assessment in Lung Cancer	5
Imaging in Renal Transplants: An Update	5
Practical Considerations When Interpreting FDG PET/CT Imaging for Staging and Treatment Response Assessment in Melanoma Patients	5
FDG PET/CT for Primary Staging of Lung Cancer and Mesothelioma	5
Imaging of Cardiac Transplantation: An Overview	5
Impact of COVID-19 on Nuclear Medicine Departments in Africa and Latin America	5
FDG PET/CT for Staging and Restaging Malignant Mesothelioma	5
A Role for PET/CT in Response Assessment of Malignant Pleural Mesothelioma	5
Role of Artificial Intelligence in PET/CT Imaging for Management of Lymphoma	5
Emerging Trends in Radionuclide Imaging of Infection and Inflammation in Pediatrics: Focus on FDG PET/CT and Immune Reactivity	5
Preclinical Research Highlighting Contemporary Targeting Mechanisms of Radiolabelled Compounds for PET Based Infection Imaging	5
Radioimmunotherapy of Non-Hodgkin B-cell Lymphoma: An update	5
Molecular Imaging of Periprosthetic Joint Infections	5
Gallium-68 Labelled Radiopharmaceuticals for Imaging Inflammatory Disorders	5
Radiation Absorbed Dose to the Embryo and Fetus from Radiopharmaceuticals	5
Positron Emission Tomography of Neuroimmune Responses in Humans: Insights and Intricacies	5
Radiation Dosimetry, Artificial Intelligence and Digital Twins: Old Dog, New Tricks	5